The problem of counterfeit medications continues to threaten patient safety and the economic viability of drug development. Innovative methods to detect counterfeit medications and to prevent them from entering into the distribution system for pharmaceuticals are needed in order to assure the integrity of our medication supply.

We believe that the academic environment at institutions such as Purdue University provides an opportunity to develop interdisciplinary approaches to the problem of counterfeit medications. To stimulate interest in the academic community and to identify research opportunities, we were pleased to host this special symposium, which was generously sponsored through an educational grant from Eli Lilly and Company.

The objective of the symposium was to provide an overview of the key issues surrounding counterfeit medications and to identify research opportunities. We have assembled a team of experts in the field who will discuss current and emerging technology, as well as opportunities for future innovation.

After the symposium, the School of Pharmacy and Pharmaceutical Sciences announced a request for proposals to provide seed funding for innovative projects addressing this important subject.